Work

Asprosin: A systemic fasting-induced adipokine with widespread physiological effects and therapeutic potential

Year: 2026
Type: article
Abstract: Asprosin, a fasting-induced adipokine derived from the C-terminal cleavage of profibrillin-1, modulates glucose homeostasis and appetite and participates in multiple physiological and pathophysiological processes. White adipose tissue is the main source of circulating asprosin, although pancreatic beta (β)-cells, salivary glands, and cartilage also produce it. Asprosin stimulates hepatic glucose release via olfactory receptor (OLFR734)-dependent G protein–cAMP–PKA signaling and promotes feeding by activating hypothalamic Agouti-related peptide (AgRP) neurons; dysregulated asprosin levels associate with obesity, insulin resistance, type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), and reproductive and cardiovascular disorders. This narrative review summarizes the discovery, sources, signaling mechanisms, systemic effects (endocrine/metabolic, gastrointestinal, nervous, cardiovascular, respiratory, reproductive, renal, musculoskeletal), and therapeutic implications of asprosin, and highlights areas where further research is needed.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,700
OpenAlex ID: W7236117492
FWCI:
Cites: 39
Cited by:
Related to: 10